These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 20193834
21. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients. Andreotti F, Testa L, Biondi-Zoccai GG, Crea F. Eur Heart J; 2006 Mar; 27(5):519-26. PubMed ID: 16143706 [Abstract] [Full Text] [Related]
22. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, Albers GW. Arch Intern Med; 2007 Feb 12; 167(3):239-45. PubMed ID: 17296878 [Abstract] [Full Text] [Related]
23. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease. Arjomand H, Cohen M, Ezekowitz MD. J Invasive Cardiol; 2004 May 12; 16(5):271-8. PubMed ID: 15152137 [Abstract] [Full Text] [Related]
25. Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks. Liu L, Chinese Cardiac Study (CCS-I) Collaborative Group. Chin Med J (Engl); 2001 Feb 12; 114(2):115-8. PubMed ID: 11780187 [Abstract] [Full Text] [Related]
27. Oral anticoagulation after myocardial infarction. Hurlen M, Arnesen H. Herz; 2008 Feb 12; 33(1):38-43. PubMed ID: 18273576 [Abstract] [Full Text] [Related]
28. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes. Testa L, Zoccai GB, Porto I, Trotta G, Agostoni P, Andreotti F, Crea F. Am J Cardiol; 2007 Jun 15; 99(12):1637-42. PubMed ID: 17560866 [Abstract] [Full Text] [Related]
30. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG, Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. N Engl J Med; 2005 Mar 31; 352(13):1305-16. PubMed ID: 15800226 [Abstract] [Full Text] [Related]
31. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ; 1994 Jan 08; 308(6921):81-106. PubMed ID: 8298418 [Abstract] [Full Text] [Related]
32. Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment. Lind M, Boman K, Johansson L, Nilsson TK, Järvholm LS, Jansson JH. J Intern Med; 2012 Mar 08; 271(3):239-46. PubMed ID: 21707795 [Abstract] [Full Text] [Related]
33. Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Coumadin Aspirin Reinfarction Study (CARS) Investigators. Lancet; 1997 Aug 09; 350(9075):389-96. PubMed ID: 9259652 [Abstract] [Full Text] [Related]
34. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy. Gathier CS, Algra A, Rinkel GJ, van der Worp HB. Cerebrovasc Dis; 2013 Aug 09; 36(1):33-7. PubMed ID: 23920426 [Abstract] [Full Text] [Related]
35. Efficacy and Safety of Triple Therapy and Dual Therapy With Direct Oral Anticoagulants Compared to Warfarin. Amano H, Saito D, Yabe T, Okubo R, Toda M, Ikeda T. Int Heart J; 2017 Aug 03; 58(4):570-576. PubMed ID: 28701676 [Abstract] [Full Text] [Related]
36. Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS). O'Connor CM, Gattis WA, Hellkamp AS, Langer A, Larsen RL, Harrington RA, Berkowitz SD, O'Gara PT, Kopecky SL, Gheorghiade M, Daly R, Califf RM, Fuster V. Am J Cardiol; 2001 Sep 01; 88(5):541-6. PubMed ID: 11524065 [Abstract] [Full Text] [Related]
37. Antithrombotic Regimens for Patients Taking Oral Anticoagulation After Coronary Intervention: A Meta-analysis of 16 Clinical Trials and 9,185 Patients. Gao XF, Chen Y, Fan ZG, Jiang XM, Wang ZM, Li B, Mao WX, Zhang JJ, Chen SL. Clin Cardiol; 2015 Aug 01; 38(8):499-509. PubMed ID: 25963316 [Abstract] [Full Text] [Related]
38. Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study. Fiore LD, Ezekowitz MD, Brophy MT, Lu D, Sacco J, Peduzzi P, Combination Hemotherapy and Mortality Prevention (CHAMP) Study Group. Circulation; 2002 Feb 05; 105(5):557-63. PubMed ID: 11827919 [Abstract] [Full Text] [Related]
39. Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment--the FinPAC study. Airaksinen KE, Korkeila P, Lund J, Ylitalo A, Karjalainen P, Virtanen V, Raatikainen P, Koivisto UM, Koistinen J. Int J Cardiol; 2013 Oct 09; 168(4):3679-82. PubMed ID: 23849104 [Abstract] [Full Text] [Related]
40. Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm. Hopper I, Skiba M, Krum H. Eur J Heart Fail; 2013 Jan 09; 15(1):69-78. PubMed ID: 23143796 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]